Remove Atrial Fibrillation Remove Hospital Remove Stroke
article thumbnail

Oral anticoagulant timing and hospitalization in newly diagnosed nonvalvular atrial fibrillation patients

Frontiers in Cardiovascular Medicine

BackgroundNon-valvular atrial fibrillation (NVAF) significantly increases ischemic stroke and systemic embolism (SE) risks. during the index visit) was linked to lower hospitalization risks compared to those initiating later (29.2% for stroke/SE-specific, p-value<0.001). Early OAC initiation (74.9%

article thumbnail

Does Screening for Atrial Fibrillation Reduce Stroke Risk?

NEJM Journal Watch - Cardiology

A 14-day monitor detected more atrial fibrillation but did not affect hospitalization rates for stroke or hemorrhage.

article thumbnail

Concomitant Drug Interactions With Non–Vitamin K Oral Anticoagulants Are Associated With Bleeding and Mortality Risk in Patients With Nonvalvular Atrial Fibrillation

Journal of the American Heart Association

BackgroundNonvitamin K oral anticoagulants prevent stroke and systemic embolism in patients with nonvalvular atrial fibrillation. Our analysis included 22 568 patients with nonvalvular atrial fibrillation (aged 75.7 Journal of the American Heart Association, Ahead of Print. years; 51.2%

article thumbnail

Case Report: Fatal atrioesophageal fistula following atrial fibrillation ablation—critical reflections on prevention

Frontiers in Cardiovascular Medicine

Radiofrequency ablation (RFA) is an important therapeutic modality for atrial fibrillation (AF), widely utilized in clinical practice due to its safety and significant efficacy. This case report describes a unique instance of a patient developing AEF following AF ablation, accompanied by ischemic stroke and myocardial infarction.

article thumbnail

Wearable heart monitor increases diagnosis of irregular heart rhythm

Science Daily - Stroke

Wearable, long-term continuous heart monitors helped identify 52% more cases of atrial fibrillation compared to usual care, but that did not lead to a reduction in hospitalizations due to stroke, according to a new study.

article thumbnail

Anthos Presents New Analysis from P2 AZALEA-TIMI 71 Study

DAIC

"Given the elevated bleeding risks associated with traditional anticoagulants, particularly when combined with antiplatelet agents, abelacimab may offer a safer alternative for patients with atrial fibrillation,” said Christian T. incidence rate for rivaroxaban to a 3.5% incidence rate for abelacimab 150 mg). [1] vs. 7.7%). [2]

article thumbnail

Popular supplement linked to increased heart, stroke risk

Becker's Hospital Review - Cardiology

Regular use of fish oil supplements can increase the risk of stroke and atrial fibrillation in the general population, but shows benefits for those with existing heart disease, a recent study found.

Stroke 111